Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4467667
Max Phase: Preclinical
Molecular Formula: C57H69NO18
Molecular Weight: 1056.17
Molecule Type: Unknown
Associated Items:
ID: ALA4467667
Max Phase: Preclinical
Molecular Formula: C57H69NO18
Molecular Weight: 1056.17
Molecule Type: Unknown
Associated Items:
Canonical SMILES: COc1c(C)c(OCc2cccc(COc3c(C)c(C)c(C(=O)Oc4c(C)c(C)c(C(=O)OC(OC)OC)c(OC)c4C)c(OC)c3C)n2)c(C)c(C)c1C(=O)Oc1c(C)c(C)c(C(=O)OC(OC)OC)c(OC)c1C
Standard InChI: InChI=1S/C57H69NO18/c1-26-30(5)44(34(9)48(63-13)40(26)52(59)73-46-32(7)28(3)42(50(65-15)36(46)11)54(61)75-56(67-17)68-18)71-24-38-22-21-23-39(58-38)25-72-45-31(6)27(2)41(49(64-14)35(45)10)53(60)74-47-33(8)29(4)43(51(66-16)37(47)12)55(62)76-57(69-19)70-20/h21-23,56-57H,24-25H2,1-20H3
Standard InChI Key: WBQCJFHWJFIRIW-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1056.17 | Molecular Weight (Monoisotopic): 1055.4515 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Ohsawa K, Yoshida M, Izumikawa M, Takagi M, Shin-Ya K, Goshima N, Hirokawa T, Natsume T, Doi T.. (2018) Synthesis and biological evaluation of thielocin B1 analogues as protein-protein interaction inhibitors of PAC3 homodimer., 26 (23-24): [PMID:30455074] [10.1016/j.bmc.2018.11.001] |
Source(1):